The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global ambulatory services market was valued at US$ 3.31 Trillion in 2021.
We expect the global ambulatory services market to exhibit a CAGR of 6.30% during 2022-2027.
The sudden outbreak of the COVID-19 pandemic has led to the increasing adoption of ambulatory services to reduce the need for hospital stays, which enables taking precautionary measures against the transmission of the coronavirus infection.
The rising demand for ambulatory services for conducting minor surgical procedures and diagnostic modalities, such as blood tests, X-rays, endoscopy, etc., is primarily driving the global ambulatory services market.
Based on the service type, the global ambulatory services market can be segmented into diagnosis, observation and consultation, treatment, wellness, and rehabilitation.
Based on the department, the global ambulatory services market has been divided into primary care offices, outpatient departments, emergency departments, surgical specialty, and medical specialty.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global ambulatory services market include Envision Healthcare, HCA Healthcare, Healthway Medical Corporation Limited, Medical Facilities Corporation, Nueterra Capital, Surgery Partners, Surgical Care Affiliates Inc. (UnitedHealth Group Incorporated), Tenet Healthcare Corporation, Terveystalo Oyj, and Universal Health Services Inc.
Immunotherapy Drugs Market by Type (Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins), Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, and Others), End User (Hospitals, Clinics, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at